board of Directors

DSAF’s Board of Directors shall be elected by the annual general meeting and shall remain on the Board for a period of 2 years.
Members of the Board may be re-elected after the period of 2 years for a maximum of an additional two-year period.

At the election in 2020 all members were prolonged with a year since there were no activities in the preceding year due to the Covid-19 pandemic.


chairwoman

Senior researcher, Ph.d., M.Sc. Public Health

Lise Geisler Bjerregaard

Center for Clinical Research and Prevention
Frederiksberg Hospital
Nordre Fasanvej 57
DK-2000 Frederiksberg

Conflicts of interest:
None

Elected in 2021 and 2023. Up for election in 2025.

 


Treasurer

Researcher, Ph.d., MSc Human Nutrition

Julie Aarestrup

Center for Klinisk Forskning og Forebyggelse
Bispebjerg og Frederiksberg Hospital
Hovedvejen, indgang 5, 1. sal
Nordre Fasanvej 57
2000 Frederiksberg

Conflicts of interest:
None

Elected in 2023. Up for election in 2025


SECRETARY

Senior researcher, Ph.d., MSc
Sofus Christian Larsen

Parker instituttet
Bispebjerg og Frederiksberg Hospital
Nordre Fasanvej 57
DK-2000 Frederiksberg

Conflicts of interest:
None

Elected in 2021 and 2023. Up for election in 2025.


Board members


Clinical dietitian og Master in the Anthropology of Health
Merete Espensen

Afdelingen for hormonsygdomme, diabetes og overvægt
Esbjerg og Grindsted Sygehus – Syddansk Universitetshospital,

Conflicts of interest:
None.

Elected in 2023. Up for election in 2025

 



Clinical Research Associate Professor, Ph.D.
Carsten Dirksen

Afdeling for Lunge-, Hormon- og Stofskiftesygdomme
Amager og Hvidovre Hospital, Hvidovre matrikel

Conflicts of interest:
Have received research funding from the Novo Nordisk Foundation, the University of Copenhagen, and the Amager-Hvidovre Hospital Research Fund. I have research collaborations with NUPO, SENS Innovation, Abbott, and Dexcom International Limited. I have served as a speaker/lecturer/meeting facilitator/consultant (with/without honorarium) for Novo Nordisk, AstraZeneca, and Eli Lilly, and have received support for congress participation from Novo Nordisk.

Elected in 2024. Up for election in 2026



Ph.d. Student, MSc Sport Sciences
Søren Gam

Afdelingen for hormonsygdomme, diabetes og overvægt
Esbjerg og Grindsted Sygehus – Syddansk Universitetshospital

Conflicts of interest:
Have received personal grants from the Region of Southern Denmark Ph.D. Foundation, Steno Diabetes Center Odense, and the Aase and Ejnar Danielsen Foundation. Additionally, I have received support from the William Demant Foundation and the Danish Association for the Study of Obesity for congress participation, as well as funding from Esbjerg and Grindsted Hospitals, the University Hospital of Southern Denmark Internationalization Fund, and the University of Southern Denmark for a research stay in the USA. None of the mentioned grants have influenced my work, and I do not own stocks in any commercial companies that could affect the work

Elected in 2024. Up for election in 2026


Deputy member


Postdoc, Ph.d., MSc Human Biology
Jens Lund

Novo Nordisk Foundation Center for Basic Metabolic Research
University of Copenhagen
Faculty of Health and Medical Sciences
Blegdamsvej 3B, Building 7 (Maersk Tower)
DK-2200 Copenhagen N

Conflicts of interest:
None

Elected in 2024. Up for election in 2026